Fongit Seed Invest
9
1M
8
4
0.11
- Areas of investment
Summary
The venture was found in Europe in Switzerland. The main department of described VC is located in the Plan-les-ouates.
We can highlight the next thriving fund investment areas, such as Biotechnology, Collaboration. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland. The fund has exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Hylomorph, Augurix, Viroblock Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The real fund results show that this VC is 42 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2019. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Fongit Seed Invest, startups are often financed by Venture Kick, MassChallenge Switzerland, Initiative Capital Romandie. The meaningful sponsors for the fund in investment in the same round are investiere | Verve Capital Partners, Zu00fcrcher Kantonal Bank, StartAngels Network. In the next rounds fund is usually obtained by BlueOcean Ventures, investiere | Verve Capital Partners, Zu00fcrcher Kantonal Bank.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 4
- Follow on index
- 0.11
- Investments by industry
- Health Care (7)
- Medical (5)
- Biotechnology (4)
- Medical Device (3)
- Personal Health (3) Show 14 more
- Investments by region
-
- Switzerland (9)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 0.78
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
EBAMed | 21 Aug 2019 | Health Care | Seed | 1M | Switzerland, Geneva |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.